Development of Metabolic Synthetic Lethality and Its Implications for Thyroid Cancer

Cancer therapies targeting genetic alterations are a topic of great interest in the field of thyroid cancer, which frequently harbors mutations in the RAS, RAF, and RET genes. Unfortunately, U.S. Food and Drug Administration-approved BRAF inhibitors have relatively low therapeutic efficacy against B...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Sang-Hyeon, Lee, Seong Eun, Kang, Yea Eun, Shong, Minho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901971/
https://www.ncbi.nlm.nih.gov/pubmed/35255601
http://dx.doi.org/10.3803/EnM.2022.1402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901971/
https://www.ncbi.nlm.nih.gov/pubmed/35255601
http://dx.doi.org/10.3803/EnM.2022.1402

Ejemplares similares